US equities |
TSLA $395.41 ▲+6.23% MU $909.79 ▲+3.67% SPCX $149.81 ▲+1.57% NVDA $216.69 ▲+2.72% META $644.71 ▲+0.33% SNDK $1,268.52 ▲+2.46% AAPL $345.76 ▼-0.56% INTC $90.74 ▲+4.34%
FinancialContent

Latest News about SGLT2

Recent news which mentions SGLT2

2023 HFSA CME Symposium - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice
Tags United States Heartfailure New Jersey
From PRLog
2023 ANNA CE Symposium- Newer Therapies to Optimize Outcomes in Patients with Chronic Kidney Disease
Tags United States Nephrology ANNA23
From PRLog
CME Symposium- Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with #SGLT2Inhibitors in Patients with #HeartFailure
Tickers CME
Tags New Jersey Cardiologist Event
From PRLog